Opaleye Management Inc.

Position in DERM — Journey Medical Corp

CIK 1595855 Boston, MA

Position in DERM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,478,000

-$2,024,400 QoQ

Shares Held

350,000

-63.5% QoQ

Ownership

1.24%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

of 71 holders

Holding Since

Mar 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Opaleye Management Inc. holds $403,826,175 across 5 Drug Manufacturers - Specialty & Generic names. DERM ranks #4 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp	2,447,500	$195,139,175
2	ETON	Eton Pharmaceuticals, Inc.	2,860,000	$103,532,000
3	HROW	Harrow, Inc.	2,400,000	$101,928,000
4	DERM	Journey Medical Corp This page	350,000	$2,478,000
5	ADCT	ADC Therapeutics SA	700,000	$749,000

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,478,000	350,000	-63.5%	Shares	Sole	2026-08-14
2026-03-31	$4,502,400	960,000	-1.5%	Shares	Sole	2026-05-15
2025-12-31	$7,517,250	975,000	+0.4%	Shares	Sole	2026-04-13
2025-09-30	$6,913,975	971,064	+922.2%	Shares	Sole	2025-11-14
2025-06-30	$682,100	95,000	+37.0%	Shares	Sole	2025-08-15
2025-03-31	$409,005	69,323	-73.3%	Shares	Sole	2025-05-15
2022-09-30	$637,860	259,293	+5.5%	Shares	Sole	2022-11-14
2022-06-30	$919,041	245,733	+266.8%	Shares	Sole	2022-08-15
2022-03-31	$323,610	67,000	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.